Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

SPONSORED BY
Related news about the opioid crisis and improving patient outcomes
Legislation aims to classify xylazine as a Schedule III drug
Antoinette Finau served as an emergency services dispatcher with the Alameda County Sheriff’s Office for nearly 3 years
Here’s an overview of what naloxone is and how responders are helping curb the opioid epidemic
Cover how to identify drug abuse vs. an opioid overdose, as well as drug administration routes and potential complications
Austin-Travis County EMS Assistant Chief Steve White said at least 65 people were treated between Monday and Wednesday
DEA proposal would make marijuana a Schedule III drug but not make it legal for recreational use
The EMS crew was about to administer epinephrine, “only they hadn’t noticed what I had; the patient’s heart rate was 268”
CalRx’s Naloxone Access Initiative will purchase 3.2M twin packs of the drug at half the market price
Data on deaths related to methamphetamine and synthetic opioids show a sudden increase
Paramedics placed a backboard on the victim and an officer sat on it while they tried to restrain him
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.